osimertinib
astrazeneca
['sclc', 'lcsm,(-blcsm)', 'nsclc', 'thanks', 'osimertinib']
thanks so much, , of , for stopping by live at the annual meeting to discuss neoadjuvant osimertinib for surgically resectable egfr-mutated nsclc. check back to to hear more! #asco23 #lcsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.